Moderna, Merck say cancer vaccine trial marks ‘landmark moment’
UPI
—
https://cdnph.upi.com/ph/st/th/2981787151544/2026/upi_com/6b9ea46975460b1ed7250d2452c58499/v1.5/Moderna-Merck-say-cancer-vaccine-trial-marks-landmark-moment.jpg" /> A cancer vaccine developed by Merck and Moderna treating patients with melanoma showed positive and promising late-stage testing results.
Merck, Moderna melanoma vaccine succeeds
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial IOL —
- Merck, Moderna Melanoma Vaccine Study Succeeds Bloomberg —
- Merck, Moderna claim encouraging melanoma vaccine trial results South China Morning Post —
- Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning The New York Times —
- Merck, Moderna Stocks Soar After Melanoma Trial Success 📹 Bloomberg — · 2min